Ivenix Wins Fierce Innovation Awards for Drug Delivery Technology and Best New Product

Ivenix Wins Fierce Innovation Awards for Drug Delivery Technology and Best New Product

Boston, December 13, 2021 – Ivenix Inc., a medical technology company with the vision to eliminate infusion-related patient harm, today announced it has been awarded the Fierce Innovation Life Science Awards for Technology Innovation in Drug Delivery Technology and Best New Product or Service from Fierce Life Sciences. This independent market intelligence publication identifies and showcases outstanding innovation driving improvements and transforming the industry.

The awards recognize the Ivenix Infusion System, an innovative infusion system and smart pump designed to enhance patient safety and transform infusion delivery. The awards follow another successful year for Ivenix, which includes expanding its customer base.

Rebecca Willumson, Vice President & Publisher, Fierce Life Sciences & Healthcare said, “Our awards program highlights the organizations that have demonstrated innovation technologies and services that have the potential to make the greatest impact for biotech and pharma companies. With hundreds of applications across six different categories, it was a challenge for our judges to select one winner in each category. The winners have shown that they are pioneers in the life sciences industry. We congratulate all of them on their excellent work.”

In designing its infusion system, Ivenix directly addressed the industry’s call to action to improve the safety of infusion pumps by rethinking every aspect of medication delivery to improve outcomes and prevent IV-related medication errors.

The Ivenix Infusion System’s patented pumping technology focuses on delivering critical medications with measured flow to maximize safety. It compensates for external conditions such as bag height, back pressure, and fluid viscosity to ensure accurate medication delivery. And it protects patients from uncontrolled flow, a continued cause of patient harm. Essentially, its innovative design and architecture have set a new standard in infusion delivery.

“Ivenix takes pride in this prestigious recognition of our passion for the elimination of infusion-related patient harm,” said Jorgen Hansen, CEO of Ivenix. “In 2022, we will be taking important steps forward in delivering large volume infusion pumps to more hospitals. To transform the present state of infusion therapy, we will place new tools in the hands of nurses and the extended care team.”

The award showcases outstanding innovation driving improvements and transforming the biotech, digital health, and pharma industries. An exclusive panel of judges review the Fierce Innovation Award applications and base their decision on effectiveness, technical innovation, competitive advantage, financial effect, and genuine innovation.
“Every year, infusion pumps are involved in more adverse events than almost any other medical technology,” says Sue Niemeier, MHA, BSN, RN, Chief Nursing Officer at Ivenix. “We know hospitals are looking for infusion solutions that meet the latest standards in safety and are also capable of expanding with future innovation. This recognition has energized our team as we continue to challenge the status quo.”

About Ivenix
Ivenix, located in North Andover, Mass., is a medical technology company with the vision of eliminating infusion-related errors by transforming infusion delivery. The Ivenix Infusion System includes a large-volume infusion pump, a portfolio of administration sets, and a suite of infusion management tools and analytics to inform care and advance clinical and operational efficiency. Infusion-related errors account for more than 50% of the 1.5 million adverse drug events reported annually to the US Food and Drug Administration (FDA). Infusion-related adverse drug events account for more than $2 billion in annual healthcare costs. Ivenix has a vision and commitment to improving infusion safety and medication delivery. Visit ivenix.com for more information.

Media Contact:
Robert Canfield
Director of Marketing
+1 (619) 325.9106